Related references
Note: Only part of the references are listed.A meta-analysis of morbidity and mortality in primary cytoreductive surgery compared to neoadjuvant chemotherapy in advanced ovarian malignancy
Helena C. Bartels et al.
GYNECOLOGIC ONCOLOGY (2019)
Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis
Helena C. Bartels et al.
PLEURA AND PERITONEUM (2019)
Aggressive surgery for advanced ovarian cancer performed by a multidisciplinary team: A retrospective analysis on a large series of patients
Stefano Rausei et al.
SURGERY OPEN SCIENCE (2019)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care
A. K. Sinno et al.
GYNECOLOGIC ONCOLOGY (2017)
LION: Lymphadenectomy in ovarian neoplasms-A prospective randomized AGO study group led gynecologic cancer intergroup trial
Philipp Harter et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Mentored experience of establishing a national peritoneal malignancy programme - Experience of first 50 operative cases
K. H. Chang et al.
EJSO (2017)
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe et al.
LANCET (2015)
Surgical cytoreduction for recurrent epithelial ovarian cancer
Thuria Al Rawahi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Centralisation of services for gynaecological cancers - A Cochrane systematic review
Yin Ling Woo et al.
GYNECOLOGIC ONCOLOGY (2012)
Multi-Center Evaluation of Post-Operative Morbidity and Mortality after Optimal Cytoreductive Surgery for Advanced Ovarian Cancer
Arash Rafii et al.
PLOS ONE (2012)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands
Flora Vernooij et al.
GYNECOLOGIC ONCOLOGY (2009)
Analysis of factors impacting operability in stage IV ovarian cancer: Rationale use of a triage system
Giovanni D. Aletti et al.
GYNECOLOGIC ONCOLOGY (2007)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Share Paper
